Goldman Sachs’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.92M Buy
85,329
+66,276
+348% +$1.49M ﹤0.01% 3441
2025
Q1
$533K Buy
+19,053
New +$533K ﹤0.01% 4222
2024
Q2
Sell
-283
Closed -$332K 4952
2024
Q1
$332K Hold
283
﹤0.01% 4154
2023
Q4
$4.12K Hold
283
﹤0.01% 4703
2023
Q3
$6.74K Sell
283
-28
-9% -$667 ﹤0.01% 4631
2023
Q2
$4.11K Sell
311
-303
-49% -$4.01K ﹤0.01% 4853
2023
Q1
$47.9K Sell
614
-8
-1% -$624 ﹤0.01% 4775
2022
Q4
$51.7K Sell
622
-187
-23% -$15.6K ﹤0.01% 4785
2022
Q3
$74K Sell
809
-185
-19% -$16.9K ﹤0.01% 4984
2022
Q2
$149K Sell
994
-1,444
-59% -$216K ﹤0.01% 4994
2022
Q1
$591K Sell
2,438
-3,595
-60% -$871K ﹤0.01% 4463
2021
Q4
$1.82M Sell
6,033
-199
-3% -$60.2K ﹤0.01% 3563
2021
Q3
$2.58M Buy
6,232
+5,966
+2,243% +$2.47M ﹤0.01% 3276
2021
Q2
$82K Sell
266
-2,699
-91% -$832K ﹤0.01% 5162
2021
Q1
$609K Sell
2,965
-925
-24% -$190K ﹤0.01% 4226
2020
Q4
$778K Sell
3,890
-324
-8% -$64.8K ﹤0.01% 3586
2020
Q3
$697K Sell
4,214
-232
-5% -$38.4K ﹤0.01% 3500
2020
Q2
$1.1M Buy
4,446
+281
+7% +$69.7K ﹤0.01% 3165
2020
Q1
$759K Buy
4,165
+386
+10% +$70.3K ﹤0.01% 3261
2019
Q4
$1.09M Sell
3,779
-423
-10% -$122K ﹤0.01% 3283
2019
Q3
$1.15M Sell
4,202
-1,723
-29% -$470K ﹤0.01% 3171
2019
Q2
$2.23M Sell
5,925
-855
-13% -$322K ﹤0.01% 2752
2019
Q1
$1.82M Sell
6,780
-1,031
-13% -$276K ﹤0.01% 2992
2018
Q4
$1.66M Sell
7,811
-203
-3% -$43.2K ﹤0.01% 2882
2018
Q3
$3.59M Sell
8,014
-724
-8% -$324K ﹤0.01% 2601
2018
Q2
$3.54M Buy
8,738
+400
+5% +$162K ﹤0.01% 2584
2018
Q1
$4.55M Buy
8,338
+5,060
+154% +$2.76M ﹤0.01% 2405
2017
Q4
$1.98M Buy
3,278
+2,030
+163% +$1.23M ﹤0.01% 2848
2017
Q3
$575K Buy
1,248
+1,099
+738% +$506K ﹤0.01% 3460
2017
Q2
$60K Buy
+149
New +$60K ﹤0.01% 4229